Study investigators aimed to improve current modified Matutes score by including highly informative markers less informative and error-prone marker.
Modified Matutes score calculated from peripheral blood or bone marrow aspirates of patients with suspected B-cell lymphoproliferative disorders.
Patient cohorts: exploratory and validation cohort.
Sensitivity 97.1% for new score versus 98.6% for Matutes score.